Form 4 Tracker
AGIOS PHARMACEUTICALS, INC.
AGIO

35 insider filings · Latest: Aug 4, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Nov 7, 2024Nov 7 9:06 PMJAMES BURNS
Proposed Sale
21,752$52.21$1.1M

View →

← Previous

Page 4 of 4

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Mar 2, 2026Mar 3 9:17 PMBrian GoffDirector, Chief Executive Officer
Option Exercise
39,50026,000(D)

View →

Mar 1, 2026Mar 3 9:17 PMBrian GoffDirector, Chief Executive Officer
Grant/Award
222,000$30.23174,000(D)

View →

Mar 2, 2026Mar 3 9:17 PMJames William BurnsChief Legal Officer
Option Exercise
17,5867,839(D)

View →

Mar 1, 2026Mar 3 9:17 PMJames William BurnsChief Legal Officer
Grant/Award
66,000$30.2352,000(D)

View →

Mar 2, 2026Mar 3 9:15 PMSarah GheuensChief Medical Officer
Option Exercise
13,6668,000(D)

View →

Mar 1, 2026Mar 3 9:15 PMSarah GheuensChief Medical Officer
Grant/Award
88,000$30.2352,000(D)

View →

Mar 2, 2026Mar 3 9:14 PMCecilia JonesChief Financial Officer
Option Exercise
16,96910,607(D)

View →

Mar 1, 2026Mar 3 9:14 PMCecilia JonesChief Financial Officer
Grant/Award
66,000$30.2352,000(D)

View →

Mar 2, 2026Mar 3 9:13 PMTsveta MilanovaChief Commercial Officer
Option Exercise
9,6668,000(D)

View →

Mar 1, 2026Mar 3 9:13 PMTsveta MilanovaChief Commercial Officer
Grant/Award
66,000$30.2352,000(D)

View →

Mar 2, 2026Mar 3 9:12 PMTheodore James Washburn Jr.Principal Accounting Officer
Option Exercise
7,4955,390(D)

View →

Mar 1, 2026Mar 3 9:12 PMTheodore James Washburn Jr.Principal Accounting Officer
Grant/Award
8,4528,452(D)

View →

Mar 1, 2026Mar 3 9:11 PMKrishnan ViswanadhanChief Corp Dev & Strategy
Grant/Award
66,000$30.2352,000(D)

View →

← Previous

Page 3 of 3